Filing Details

Accession Number:
0001567619-21-022459
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-22 19:03:33
Reporting Period:
2021-12-20
Accepted Time:
2021-12-22 19:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185191 T James Treace C/O Treace Medical Concepts, Inc.
203 Fort Wade Road, Suite 150
Ponte Vedra FL 32081
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-20 15,719 $15.69 1,413,227 No 4 S Indirect By J&A Group LLC
Common Stock Disposition 2021-12-20 400 $16.30 1,412,827 No 4 S Indirect By J&A Group LLC
Common Stock Disposition 2021-12-20 406,183 $0.00 1,006,644 No 4 J Indirect By J&A Group LLC
Common Stock Disposition 2021-12-20 406,183 $0.00 600,461 No 4 J Indirect By J&A Group LLC
Common Stock Disposition 2021-12-20 270,789 $0.00 329,672 No 4 J Indirect By J&A Group LLC
Common Stock Disposition 2021-12-20 270,789 $0.00 58,883 No 4 J Indirect By J&A Group LLC
Common Stock Acquisiton 2021-12-20 406,183 $0.00 1,006,183 No 4 J Indirect By spouse
Common Stock Acquisiton 2021-12-20 406,183 $0.00 1,461,441 No 4 J Direct
Common Stock Disposition 2021-12-21 13,478 $16.12 45,405 No 4 S Indirect By J&A Group LLC
Common Stock Disposition 2021-12-21 1,403 $16.36 44,002 No 4 S Indirect By J&A Group LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By J&A Group LLC
No 4 S Indirect By J&A Group LLC
No 4 J Indirect By J&A Group LLC
No 4 J Indirect By J&A Group LLC
No 4 J Indirect By J&A Group LLC
No 4 J Indirect By J&A Group LLC
No 4 J Indirect By spouse
No 4 J Direct
No 4 S Indirect By J&A Group LLC
No 4 S Indirect By J&A Group LLC
Footnotes
  1. Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $16.10 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.275 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.
  5. Pro rata distribution from J&A Group, LLC to member.
  6. Includes pro rata distribution from J&A Group, LLC.
  7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.38 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.